Powder could replace needles and clips for stomach bleeds
NCT ID NCT06188585
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares a new hemostatic powder, Nexpowder™, to standard treatments (like clips, heat, or injections) for stopping high-risk bleeding in the upper digestive tract. About 278 adults with active bleeding from ulcers, tumors, or tears will be randomly assigned to one of the two approaches. The main goal is to see if the powder works as well as standard therapy in preventing further bleeding within 7 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Nexpowder™ (hemostatic powder)
What this could lead to
If successful, this could offer a simpler, equally effective first-line treatment for serious upper gastrointestinal bleeding, potentially reducing the need for more complex procedures.
What could go wrong
This is a non-inferiority trial, meaning it only aims to show the powder is not worse than standard care, not that it is better. The study is still recruiting, and results may not apply to all bleeding types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE GASTROINTESTINAL BLEEDING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
Contact
Contact
-
Cleveland Clinic London
RECRUITINGLondon, United Kingdom
Contact
Contact
-
Copenhagen University Hospital
RECRUITINGHvidovre, Denmark
Contact
Contact
-
Emek Medical Center
RECRUITINGAfula, Israel
Contact
Contact
-
McGill University
RECRUITINGMontreal, Quebec, Canada
Contact
Contact
-
NYU Langone
RECRUITINGNew York, New York, 10016, United States
Contact
Contact
-
Northwell Health
RECRUITINGManhasset, New York, 11030, United States
Contact
Contact
-
Odense University Hospital
RECRUITINGOdense, Denmark
Contact
-
RUSH University
RECRUITINGChicago, Illinois, 60612, United States
Contact
Contact
-
Rutgers University
RECRUITINGPiscataway, New Jersey, 08901, United States
Contact
Contact
-
St. Antoine
RECRUITINGParis, France
Contact
Contact
-
St. Michael's Hospital
RECRUITINGToronto, Canada
Contact
-
Vancouver General Hospital
RECRUITINGVancouver, Canada
Contact
-
Yale
RECRUITINGNew Haven, Connecticut, 06520, United States
Contact
Contact